Deals and Client Wins Maples BVI Advises Biohaven Pharmaceutical on up to US$950 million of New Funding
03 Sep 2020
Maples and Calder, the Maples Group's law firm was pleased to advise its longstanding client, Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") on the British Virgin Islands (BVI) legal aspects of its US$500 million non-dilutive term loan with Sixth Street and its US$450 million funding agreement with Royalty Pharma. These transactions relate to separate funding arrangements with Sixth Street and Royalty Pharma with both deals closing in August 2020. The new funding will be used, in part, for the development, promotion and commercial launch of NURTEC ODT, the company's latest FDA-approved migraine medication.
Chris Newton, a Corporate Partner based in the Group's BVI office worked alongside Associate, Amel Wehden and Chartered Legal Executive, Chloe Harris in advising Biohaven, a BVI entity that is listed on the New York Stock Exchange, and other entities within the group.
Commenting on the transaction, Chris said, "We were delighted to assist Biohaven in securing this funding which will support the delivery of NURTEC ODT to patients around the globe. This cash injection will help to support the long term success of Biohaven and we very much look forward to continuing to work with the Biohaven team as their business progresses."
A longstanding client of the Group, the BVI team has acted as Biohaven's legal adviser since its incorporation, advising on its IPO in 2017 as well as other funding arrangements and continues to advise the company on its corporate matters.
Maples and Calder, the Maples Group's law firm, is proud to announce that it has once again achieved top-tier rankings in The Legal 500 Caribbean 2021 Guide, further demonstrating its leading position in the region.Read more
17 Nov 2020
Maples Group Supports E-Scooter Producer Ninebot in First-Ever Listing of CDRs on China's STAR Market
The Maples Group was pleased to support Ninebot Limited ("Ninebot") on the first-ever listing of Chinese Depositary Receipts ("CDRs") on the Shanghai Stock Exchange Science and Technology Innovation Board ("STAR Market"). The offering, which closed on 29 October 2020, was a listing of 70.4 million CDRs that raised approximately RMB 1.33 billion.Read more
29 Oct 2020
Maples and Calder, the Maples Group's law firm, was pleased to act as Cayman Islands and British Virgin Islands counsel to Baidu, Inc. (the "Issuer") on its issue of an aggregate of US$650million 1.720% notes due 2026 and US$300million 2.375% notes due 2030, which closed on 9 October 2020.Read more
29 Oct 2020
The Maples Group is pleased to announce the appointment of Claire Morrissey to its growing Irish office.Read more
28 Oct 2020
Maples and Calder, the Maples Group's law firm was delighted to once again act as lead Jersey counsel for Apache Capital Partners on a recent transaction.Read more
21 Oct 2020
The Maples Group is pleased to announce the appointment of Mark Crichton to its Jersey office.Read more
15 Oct 2020